Disc Medicine, Inc. Income Tax Expense
Disc Medicine, Inc. (IRON) reported Income Tax Expense of $69.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxExpenseBenefit · last filed 2026-07-30
- Disc Medicine, Inc. income tax expense (benefit) for the quarter ending 2026-06-30 was $69.00K, a 32.69% increase year-over-year.
- Disc Medicine, Inc. income tax expense (benefit) for the quarter ending 2026-03-31 was $51.00K, a 57.14% decline year-over-year.
- Disc Medicine, Inc. income tax expense (benefit) for the quarter ending 2025-12-31 was $88.00K, a 50.00% decline year-over-year.
- Disc Medicine, Inc. income tax expense (benefit) for the quarter ending 2025-09-30 was $102.00K, a 10.53% decline year-over-year.
- Disc Medicine, Inc. income tax expense (benefit) for fiscal 2025 was $361.00K, a 1.69% increase from fiscal 2024.
- Disc Medicine, Inc. income tax expense (benefit) for fiscal 2024 was $355.00K, a 258.59% increase from fiscal 2023.
- Disc Medicine, Inc. income tax expense (benefit) for fiscal 2023 was $99.00K.
- Disc Medicine, Inc. income tax expense (benefit) for fiscal 2022 was $0.00.
| Period end | Income Tax Expense (Benefit) 3 month | Income Tax Expense (Benefit) 6 month | Income Tax Expense (Benefit) 9 month | Income Tax Expense (Benefit) 12 month |
|---|---|---|---|---|
| 2026-06-30 | $69.00K 10-Q · filed 2026-07-30 | $120.00K 10-Q · filed 2026-07-30 | $208.00K derived: sum of 3 quarters · filed 2026-07-30 | $310.00K derived: sum of 4 quarters · filed 2026-07-30 |
| 2026-03-31 | $51.00K 10-Q · filed 2026-05-05 | $139.00K derived: sum of 2 quarters · filed 2026-05-05 | $241.00K derived: sum of 3 quarters · filed 2026-05-05 | $293.00K derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-12-31 | $88.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $190.00K derived: sum of 2 quarters · filed 2026-02-26 | $242.00K derived: sum of 3 quarters · filed 2026-07-30 | $361.00K 10-K · filed 2026-02-26 |
| 2025-09-30 | $102.00K 10-Q · filed 2025-11-06 | $154.00K derived: sum of 2 quarters · filed 2026-07-30 | $273.00K 10-Q · filed 2025-11-06 | $449.00K derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-06-30 | $52.00K 10-Q · filed 2026-07-30 | $171.00K 10-Q · filed 2026-07-30 | $347.00K derived: sum of 3 quarters · filed 2026-07-30 | $461.00K derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-03-31 | $119.00K 10-Q · filed 2026-05-05 | $295.00K derived: sum of 2 quarters · filed 2026-05-05 | $409.00K derived: sum of 3 quarters · filed 2026-05-05 | $469.00K derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | $176.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $290.00K derived: sum of 2 quarters · filed 2026-02-26 | $350.00K derived: sum of 3 quarters · filed 2026-02-26 | $355.00K 10-K · filed 2026-02-26 |
| 2024-09-30 | $114.00K 10-Q · filed 2025-11-06 | $174.00K derived: sum of 2 quarters · filed 2025-11-06 | $179.00K 10-Q · filed 2025-11-06 | $211.00K derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $60.00K 10-Q · filed 2025-08-07 | $65.00K 10-Q · filed 2025-08-07 | $97.00K derived: sum of 3 quarters · filed 2026-02-26 | $117.00K derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $5.00K 10-Q · filed 2025-05-07 | $37.00K derived: sum of 2 quarters · filed 2026-02-26 | $57.00K derived: sum of 3 quarters · filed 2026-02-26 | $81.00K derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $32.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $52.00K derived: sum of 2 quarters · filed 2026-02-26 | $76.00K derived: sum of 3 quarters · filed 2026-02-26 | $99.00K 10-K · filed 2026-02-26 |
| 2023-09-30 | $20.00K 10-Q · filed 2024-11-12 | $44.00K derived: sum of 2 quarters · filed 2024-11-12 | $67.00K 10-Q · filed 2024-11-12 | $67.00K derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $24.00K 10-Q · filed 2024-08-08 | $47.00K 10-Q · filed 2024-08-08 | $47.00K derived: sum of 3 quarters · filed 2024-08-08 | $47.00K derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $23.00K 10-Q · filed 2024-05-09 | $23.00K derived: sum of 2 quarters · filed 2024-05-09 | $23.00K derived: sum of 3 quarters · filed 2024-05-09 | $23.00K derived: sum of 4 quarters · filed 2024-05-09 |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-21 | $0.00 derived: sum of 2 quarters · filed 2024-03-21 | $0.00 derived: sum of 3 quarters · filed 2024-03-21 | $0.00 10-K · filed 2024-03-21 |
| 2022-09-30 | $0.00 10-Q · filed 2023-11-09 | $0.00 derived: sum of 2 quarters · filed 2023-11-09 | $0.00 10-Q · filed 2023-11-09 | |
| 2022-06-30 | $0.00 10-Q · filed 2023-08-11 | $0.00 10-Q · filed 2023-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| MBX Biosciences, Inc. (MBX) | United States | $2.664B | -25.36 |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| NewAmsterdam Pharma Co N.V. (NAMS) | $2.719B | -15.37 | |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |